ELI LILLY & Co (LLY) operating KPIs
LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3026% above fair value
$1417.54+43.84 (+3.19%)
Close on Oct 30, 2026Market cap $1.33TP/E 46.0Yield 0.44%
Eli Lilly fX forward contracts (not designated as hedging instruments) — Short notional ($M) ($M)
Form 10-Q / 10-K Financial Instruments Note
Latest, FY2025
9,264
Period ended Dec 31, 2025
Change on a year earlier
+4.7%
8,848 in FY2024
History
2 years
Since FY2024
Sources
2
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | FX forward contracts (not designated as hedging instruments) — Short notional ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 9,264 | +4.7% | Form 10-Q (filed 2026-08-05) ↗ |
| FY2024 | Dec 31, 2024 | 8,848 | – | Form 10-K (filed 2026-02-12) ↗ |
Cite this data
StockData. (2026). Eli Lilly FX forward contracts (not designated as hedging instruments) — Short notional ($M) ($M), annual FY2024–FY2025 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/deriv_fx_fwd_unhedged_short
See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.